LAI, YINGJIE,LIANG, JUN,MAGNUSON, STEVEN R.,ROBARGE, KIRK D.,TSUI, VICKIE HSAIO-WEI,ZHANG, BIRONG
申请号:
CA2845409
公开号:
CA2845409A1
申请日:
2012.09.19
申请国别(地区):
CA
年份:
2013
代理人:
摘要:
The invention provides TYK2 inhibitors of Formulas (la-lb), stereoisomers or pharmaceutically acceptable salts thereof, wherein A, X, Ra, R1, R2, R4, R5 and R16 are defined herein, a pharmaceutical composition that includes a compound of Formulas (la-lb) and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of using the compound or composition in the therapy of inflammatory diseases.